[{"Assets_0_Q1_USD":137902000.0,"CommonStockSharesOutstanding_0_Q1_shares":34280000.0,"EarningsPerShareBasic_1_Q1_USD":0.03,"EarningsPerShareDiluted_1_Q1_USD":0.02,"NetIncomeLoss_1_Q1_USD":878000.0,"StockholdersEquity_0_Q1_USD":122953000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":37742000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":34146000.0,"Ticker":"GKOS","CIK":"1192448","name":"GLAUKOS CORP","OfficialName":"Glaukos Corporation Common Stock","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2869781865.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NYSE","SP500":"nan","filed":"20170504"}]